Galmed Pharmaceuticals
GLMD
14 hedge funds and large institutions have $166K invested in Galmed Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
63% more capital invested
Capital invested by funds: $102K → $166K (+$64.3K)
40% more funds holding
Funds holding: 10 → 14 (+4)
0.34% more ownership
Funds ownership: 0.17% → 0.51% (+0.34%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$106K |
| 2 |
Two Sigma Advisers
New York
|
+$36.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$15.9K |
| 4 |
Jane Street
New York
|
+$14.2K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14.4K |
| 2 |
WANY
Wealthspire Advisors (New York)
New York
|
-$29 |
| 3 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$3 |
GLMD Hedge Fund Activity: Q4 2025 in Review
14 of the 8,264 institutional investors tracked by Wall St. Rank reported a position in Galmed Pharmaceuticals (GLMD) for Q4 2025, worth a combined $166K — up 63% from $102K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GLMD positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $106K. The largest seller was Citadel Advisors, cutting an estimated $14.4K.
- 14 institutional investors held Galmed Pharmaceuticals (GLMD) as of Q4 2025, up from 10 in Q3 2025.
- Funds reported $166K of Galmed Pharmaceuticals stock for Q4 2025, up 63% quarter-over-quarter.
- 5 funds opened new Galmed Pharmaceuticals positions in Q4 2025 and 1 closed out, a net change of +4 holders.
- The largest Galmed Pharmaceuticals buyer in Q4 2025 was Two Sigma Investments, an estimated $106K added.
- The largest Galmed Pharmaceuticals seller in Q4 2025 was Citadel Advisors, an estimated $14.4K sold.
Based on aggregated 13F filings for Q4 2025.